Statement: the primary clinical trial accepts patients diagnosed with hormone receptor positive advanced breast cancer, but without any prior chemotherapy treatment.
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).